Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan

NCT00748215 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapeutic Agent Toxicity
Colorectal Cancer
Diarrhea

Interventions

DRUG: calcium aluminosilicate anti-diarrheal
OTHER: placebo

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]